Fang Y, Chen Y, Niu S, Lyu Z, Tian Y, Shen X
J Biomed Sci. 2025; 32(1):32.
PMID: 40025566
PMC: 11871619.
DOI: 10.1186/s12929-025-01125-x.
Chen S, Shen C, Zeng X, Sun L, Luo F, Wan R
Front Microbiol. 2025; 16:1515364.
PMID: 39959156
PMC: 11826063.
DOI: 10.3389/fmicb.2025.1515364.
Takamaru H, Tsay C, Shiba S, Yachida S, Saito Y
J Anus Rectum Colon. 2025; 9(1):20-24.
PMID: 39882224
PMC: 11772794.
DOI: 10.23922/jarc.2024-080.
Hasan A, Cavalu S, Kira A, Hamad R, Abdel-Reheim M, Elmorsy E
Int J Nanomedicine. 2025; 20():741-770.
PMID: 39845772
PMC: 11752831.
DOI: 10.2147/IJN.S502833.
Rong J, Chen X, Li Z, Li B, Sun Y, Miao Y
Front Oncol. 2025; 14:1498328.
PMID: 39743994
PMC: 11688226.
DOI: 10.3389/fonc.2024.1498328.
A two-sample Mendelian randomization study reveals the causal effects of statin medication on gut microbiota abundance in the European population.
Zhou P, Qiu C, Zhuang Z, Shi K, Yang Z, Ding Y
Front Genet. 2024; 15:1380830.
PMID: 39734574
PMC: 11674602.
DOI: 10.3389/fgene.2024.1380830.
Gut mucosal microbiota profiles linked to development of positional-specific human colorectal cancer.
Zhang C, Ma M, Zhao Z, Feng Z, Chu T, Wang Y
AIMS Microbiol. 2024; 10(4):812-832.
PMID: 39628718
PMC: 11609426.
DOI: 10.3934/microbiol.2024035.
Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of .
Koliarakis I, Lagkouvardos I, Vogiatzoglou K, Tsamandouras I, Intze E, Messaritakis I
Int J Mol Sci. 2024; 25(16).
PMID: 39201711
PMC: 11354820.
DOI: 10.3390/ijms25169025.
Environmentally dependent interactions shape patterns in gene content across natural microbiomes.
Crocker K, Lee K, Chakraverti-Wuerthwein M, Li Z, Tikhonov M, Mani M
Nat Microbiol. 2024; 9(8):2022-2037.
PMID: 38977908
PMC: 11386527.
DOI: 10.1038/s41564-024-01752-4.
Exploiting bacteria for cancer immunotherapy.
Kwon S, Ngo H, Son J, Hong Y, Min J
Nat Rev Clin Oncol. 2024; 21(8):569-589.
PMID: 38840029
DOI: 10.1038/s41571-024-00908-9.
Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis.
Messaritakis I, Koulouris A, Boukla E, Vogiatzoglou K, Lagkouvardos I, Intze E
Cancers (Basel). 2024; 16(10).
PMID: 38792001
PMC: 11119035.
DOI: 10.3390/cancers16101923.
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids.
Lachance G, Robitaille K, Laaraj J, Gevariya N, Varin T, Feldiorean A
Nat Commun. 2024; 15(1):3431.
PMID: 38654015
PMC: 11039720.
DOI: 10.1038/s41467-024-45332-w.
Loss of symbiotic and increase of virulent bacteria through microbial networks in Lynch syndrome colon carcinogenesis.
Sadeghi M, Mestivier D, Carbonnelle E, Benamouzig R, Khazaie K, Sobhani I
Front Oncol. 2024; 13:1313735.
PMID: 38375206
PMC: 10876293.
DOI: 10.3389/fonc.2023.1313735.
Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets.
Abdullah S, Abdullah S, Hussen B, Younis Y, Rasul M, Taheri M
Noncoding RNA Res. 2024; 9(1):236-252.
PMID: 38192436
PMC: 10771991.
DOI: 10.1016/j.ncrna.2023.12.002.
Microbial metabolites are involved in tumorigenesis and development by regulating immune responses.
Liu J, Tian R, Sun C, Guo Y, Dong L, Li Y
Front Immunol. 2024; 14:1290414.
PMID: 38169949
PMC: 10758836.
DOI: 10.3389/fimmu.2023.1290414.
Alterations in urinary microbiota composition in urolithiasis patients: insights from 16S rRNA gene sequencing.
Liu H, Hu Q, Yan Q, Hao Z, Liang C
Front Cell Infect Microbiol. 2023; 13:1266446.
PMID: 38029257
PMC: 10644862.
DOI: 10.3389/fcimb.2023.1266446.
fermentation enhances the inhibitory effects of supplementation on tumorigenic serotonin and Wnt pathways and promotes ROS-mediated apoptosis of Caco-2 cells.
Lin T, Soorneedi A, Guan Y, Tang Y, Shi E, Moore M
Front Pharmacol. 2023; 14:1203087.
PMID: 37663253
PMC: 10469317.
DOI: 10.3389/fphar.2023.1203087.
Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?.
Ren J, Li H, Zeng G, Pang B, Wang Q, Wei J
Front Pharmacol. 2023; 14:1178596.
PMID: 37324466
PMC: 10267478.
DOI: 10.3389/fphar.2023.1178596.
Elevated serum β-hydroxybutyrate, a circulating ketone metabolite, accelerates colorectal cancer proliferation and metastasis via ACAT1.
Mao T, Qin F, Zhang M, Li J, Li J, Lai M
Oncogene. 2023; 42(23):1889-1899.
PMID: 37185457
DOI: 10.1038/s41388-023-02700-y.
A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria.
Liang J, Zeng Y, Lau E, Sun Y, Huang Y, Zhou T
Cells. 2023; 12(9).
PMID: 37174650
PMC: 10177585.
DOI: 10.3390/cells12091244.